FindTrial
Sign In

A Medical Records Based Study for the Effectiveness of Extracorporeal Membrane Oxygenation in Patients with Severe Novel Coronavirus Pneumonia (COVID-19)

A Medical Records Based Study for the Effectiveness of Extracorporeal Membrane Oxygenation in Patients with Severe Novel Coronavirus Pneumonia (COVID-19)

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2000029949
Enrollment
Unknown
Registered
2020-02-16
Start date
2020-02-16
Completion date
Unknown
Last updated
2024-08-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Novel Coronavirus Pneumonia (COVID-19)

Interventions

Extracorporeal Membrane Oxygenation Group:None

Sponsors

Emergency Department of Zhongnan hospital of Wuhan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Aged >=18 years; 2. Diagnosed of 2019-nCoV infection with "guideline of the diagnose and treatment of 2019-nCoV (tested the fourth edition)" published by National Health Committees of Peoples' Republic Country. 3. Failed by conventional treatment needing ECMO support.

Exclusion criteria

Exclusion criteria: Absolutely forbidden criteria for ECMO application

Design outcomes

Primary

MeasureTime frame
inhospital mortality;28th day mortality after admission;—

Secondary

MeasureTime frame
inhospital length;ECMO treatment length;—

Countries

China

Contacts

Public ContactYan Zhao

Emergency Department of Zhongnan hospital of Wuhan University

doctoryanzhao@whu.edu.cn+86 27 6781 2656

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026